RALLYBIO CORP

Rallybio (RLYB) climbs 1.46 % to $16.64 – a biotech firm eyeing rare‑disease therapies with a market cap of $88.4 M and a strong 52‑week range. Click for details.

Rallybio (RLYB) trades up 0.18% to $16.22, with a $86.8M market cap and 1.7M USD volume—compare its performance to peers and its biotech pipeline.